Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMLX Amylyx Pharmaceuticals, Inc.

交易中 07-17 13:16:17 EDT

2.13

-0.23

-9.96%

最高2.37	最低2.12	成交量92.85万
今开2.35	昨收2.36	日振幅10.59%
总市值1.45亿	流通市值1.10亿	总股本6,801万
成交额209.00万	换手率1.80%	流通股本5,154万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals, Inc.","latestPrice":2.125,"timestamp":1721236565671,"preClose":2.36,"halted":0,"volume":928548,"delay":0,"floatShares":51537170,"shares":68005749,"eps":-1.054054,"marketStatus":"交易中","marketStatusCode":2,"change":-0.235,"latestTime":"07-17 13:16:17 EDT","open":2.35,"high":2.37,"low":2.12,"amount":2089969.9885476,"amplitude":0.105932,"askPrice":2.13,"askSize":1882,"bidPrice":2.12,"bidSize":1317,"shortable":0,"etf":0,"ttmEps":-1.054054,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721246400000},"adr":0,"listingDate":1641531600000,"adjPreClose":2.36,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.3409,"preClose":2.36,"latestTime":"09:28 EDT","volume":10029,"amount":23711.695077,"timestamp":1721222903416},"postHourTrading":{"tag":"盘后","latestPrice":2.33,"preClose":2.36,"latestTime":"18:54 EDT","volume":12761,"amount":30159.7189,"timestamp":1721170469794},"volumeRatio":0.350941,"impliedVol":1.2333,"impliedVolPercentile":0.7183},"requestUrl":"/m/hq/s/AMLX","defaultTab":"news","newsList":[{"id":"2452169171","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘快速下跌5.08%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452169171","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452169171?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:42","pubTimestamp":1721230959,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时42分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.08%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.06%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234239aefa289d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234239aefa289d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2451915533","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅拉升5.09%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451915533","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451915533?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:15","pubTimestamp":1721139358,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时15分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.09%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Silo Pharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1880.24%、1106.89%、100.27%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.、Scisparc Ltd.，振幅分别为48.60%、43.93%、40.48%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221558941f774a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716221558941f774a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2451623675","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451623675","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451623675?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:31","pubTimestamp":1721050286,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时31分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.09%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Scinai Immunotherapeutics Ltd、Humacyte Inc C/Wts 27/08/2026 、Solid Biosciences Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为891.46%、92.35%、44.69%，振幅较大的相关个股有Scinai Immunotherapeutics Ltd、Aeon Biopharma, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为17.98%、13.93%、8.80%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213126af9264ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213126af9264ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2450757890","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450757890","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450757890?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:32","pubTimestamp":1720618326,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时32分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.45%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Kazia Therapeutics Limited涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为829.31%、530.83%、356.25%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Longeveron Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为48.28%、29.27%、19.01%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213206941f5d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213206941f5d2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2450089514","title":"BUZZ-完成低血糖药物收购后，Amylyx公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2450089514","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450089514?lang=zh_cn&edition=full","pubTime":"2024-07-10 19:43","pubTimestamp":1720611796,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月10日 - ** 制药商Amylyx Pharmaceuticals   股价盘前上涨约6.1%至1.75美元** 该公司称已完成 (link) 对破产制药商 Eiger BioPharmaceuticals 的    治疗低血糖的试验性药物阿维西肽的收购** 上个月，该公司同意 (link) 收购 GLP-1 拮抗剂药物** 预计 AMLX 将于 2025 年第一季度开始该药的后期研究** 截至上次收盘，股价累计下跌 88.8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4007","AMLX"],"gpt_icon":0},{"id":"2448169225","title":"Amylyx Pharmaceuticals, Inc.盘中异动 临近午盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448169225","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448169225?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:01","pubTimestamp":1719936061,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时01分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.05%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703000102941f32ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703000102941f32ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2446868540","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446868540","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446868540?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:39","pubTimestamp":1719581976,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时39分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.22%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213937941f250e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213937941f250e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2445072966","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.06%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072966","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445072966?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:46","pubTimestamp":1719236763,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时46分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.06%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214603aef65186&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624214603aef65186&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2445571841","title":"Amylyx 将收购破产的艾格公司治疗低血糖的试验性药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2445571841","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445571841?lang=zh_cn&edition=full","pubTime":"2024-06-22 05:59","pubTimestamp":1719007161,"startTime":"0","endTime":"0","summary":"    路透6月21日 - ，艾格在周五提交的一份文件中说，Amylyx Pharmaceuticals   已同意以3510万美元的价格购买破产制药商艾格生物制药公司  治疗低血糖的试验性药物的权利。Amylyx收购avexitide公司意味着该公司将涉足代谢性疾病的药物开发。Amylyx公司没有立即回应路透的置评请求。艾格已在中期研究中测试了阿维昔肽，作为减肥手术引起的低血糖和一种被称为先天性高胰岛素血症的代谢紊乱的潜在治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","IE00BJT1NW94.SGD","LU1064131342.USD","LU2237443549.SGD","LU1551013342.USD","LU0198837287.USD","LU1267930730.SGD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU0061475181.USD","LU0882574055.USD","LU0820561909.HKD","LU0943347566.SGD","LU0122379950.USD","LU1712237335.SGD","LU0097036916.USD","LU0114720955.EUR","LU0058720904.USD","LU0079474960.USD","LU2264538146.SGD","IE00BFTCPJ56.SGD","LU2237443622.USD","BK4533","GB00BDT5M118.USD","LU0708995401.HKD","BK4585","IE00B2B36J28.USD","LU0640476718.USD","LU0882574139.USD","LLY","BK4534","IE00B1BXHZ80.USD","LU1623119135.USD","LU0256863811.USD","IE0009355771.USD","LU0385154629.USD","LU0689472784.USD","LU1551013425.SGD","LU2237443978.SGD","LU2237443382.USD","LU1280957306.USD","IE0002141913.USD","LU0466842654.USD","LU1804176565.USD","LU2491049909.HKD","BK4007","LU2491050071.SGD","IE0004445239.USD","LU2265009873.SGD","AMLX"],"gpt_icon":0},{"id":"2434851808","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.29%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434851808","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434851808?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:32","pubTimestamp":1715347932,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时32分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.29%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102132137a5940aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102132137a5940aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2434090239","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅下挫5.96%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434090239","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434090239?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:30","pubTimestamp":1715261443,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时30分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.96%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213044861ec17d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213044861ec17d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2433818731","title":"Amylyx Pharmaceuticals Inc    预计每股亏损 1 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433818731","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433818731?lang=zh_cn&edition=full","pubTime":"2024-05-08 03:28","pubTimestamp":1715110103,"startTime":"0","endTime":"0","summary":"   * Amylyx Pharmaceuticals Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 Amylyx Pharmaceuticals Inc 的平均预期是每股亏损 1 美分。* 华尔街对 Amylyx Pharmaceuticals Inc 的 12 个月目标价中位数为 3.75 美元，高于上一次收盘价 1.99 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2432033229","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432033229","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432033229?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743166,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.00%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为62.38%、21.87%、10.76%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321324687e8577f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321324687e8577f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2432632607","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432632607","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432632607?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:02","pubTimestamp":1714658577,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时02分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.18%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222025787e85578&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222025787e85578&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2432771445","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432771445","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432771445?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:40","pubTimestamp":1714570800,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时40分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.52%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Cytomx Therapeutics, Inc.、Palisade Bio, Inc.、Tg Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为492.41%、41.32%、16.14%，振幅较大的相关个股有Promis Neurosciences Inc.、Carmell Corporation、Cytomx Therapeutics, Inc.，振幅分别为30.95%、21.50%、20.25%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121400187e852c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121400187e852c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2431659338","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431659338","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431659338?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:35","pubTimestamp":1714397705,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时35分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.11%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Mesoblast Ltd涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为446.61%、23.69%、11.24%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Akari Therapeutics Plc，振幅分别为28.57%、17.43%、12.76%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921350687e84bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921350687e84bce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2430231535","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231535","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430231535?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:33","pubTimestamp":1714062803,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日00时33分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.05%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260033237a55bffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260033237a55bffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2428086662","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428086662","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428086662?lang=zh_cn&edition=full","pubTime":"2024-04-20 01:28","pubTimestamp":1713547692,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日01时28分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.05%。截至发稿，该股报1.88美元/股，成交量88.9055万股，换手率1.31%，振幅6.82%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420012812861e780a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420012812861e780a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2427887259","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427887259","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427887259?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:42","pubTimestamp":1713206576,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时42分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.12%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041602425687e80864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041602425687e80864&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2426295885","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426295885","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426295885?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:36","pubTimestamp":1712856963,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时36分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.28%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Candel Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为775.83%、578.37%、512.11%，振幅较大的相关个股有Veru Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Rallybio Corporation，振幅分别为53.23%、52.42%、50.92%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041201360487e7fae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041201360487e7fae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":0.4303},{"period":"1month","weight":0.439},{"period":"3month","weight":0.18},{"period":"6month","weight":-0.8414},{"period":"1year","weight":-0.8964},{"period":"ytd","weight":-0.8397}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。他们的任务是开发治疗方法，通过让神经元存活来改变肌萎缩侧索硬化症和一系列神经退行性疾病的治疗模式。该公司正在寻求其候选产品AMX0035的商业化，他们认为这是第一个在ALS患者的大规模临床试验中显示出功能和生存益处的候选药物。该公司相信AMX0035有潜力成为一种基础疗法，这意味着它可以单独使用或与其他疗法结合使用，以改变广泛的神经退行性疾病的治疗模式。","exchange":"NASDAQ","name":"Amylyx Pharmaceuticals, Inc.","nameEN":"Amylyx Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amylyx Pharmaceuticals, Inc.,AMLX,Amylyx Pharmaceuticals, Inc.股票,Amylyx Pharmaceuticals, Inc.股票老虎,Amylyx Pharmaceuticals, Inc.股票老虎国际,Amylyx Pharmaceuticals, Inc.行情,Amylyx Pharmaceuticals, Inc.股票行情,Amylyx Pharmaceuticals, Inc.股价,Amylyx Pharmaceuticals, Inc.股市,Amylyx Pharmaceuticals, Inc.股票价格,Amylyx Pharmaceuticals, Inc.股票交易,Amylyx Pharmaceuticals, Inc.股票购买,Amylyx Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}